X BODY Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 16

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $155M

X BODY General Information

Description

Developer of human monoclonal antibody therapeutics. The company develops technologies that produce stable and functional binding molecules enabling the discovery of human antibodies against therapeutic target.

Contact Information

Website
www.x-bodybiosciences.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 100 Beaver Street
  • Suite 101
  • Waltham, MA 02453
  • United States
+1 (781)
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Acquirer
Juno Therapeutics
Vertical(s)
Oncology
Corporate Office
  • 100 Beaver Street
  • Suite 101
  • Waltham, MA 02453
  • United States
+1 (781)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

X BODY Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 01-Jun-2015 $155M Completed Generating Revenue
4. Early Stage VC 08-Apr-2015 Completed Generating Revenue
3. Early Stage VC (Series A) 23-Jan-2012 Completed Startup
2. Grant 01-Nov-2010 $500K $1M Completed Startup
1. Early Stage VC (Series A) 29-Dec-2008 $1M $1M Completed Startup
To view X BODY’s complete valuation and funding history, request access »

X BODY Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view X BODY’s complete cap table history, request access »

X BODY Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of human monoclonal antibody therapeutics. The company develops technologies that produce stable and functiona
Biotechnology
Waltham, MA
16 As of 2015

Pampisford, United Kingdom
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

X BODY Competitors (42)

One of X BODY’s 42 competitors is PhoreMost, a Venture Capital-Backed company based in Pampisford, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PhoreMost Venture Capital-Backed Pampisford, United Kingdom
CytomX Therapeutics Formerly VC-backed South San Francisco, CA
Compass Therapeutics Formerly VC-backed Boston, MA
Mayflower Bioscience Formerly Accelerator/Incubator backed Saint Louis, MO
Abcam Corporate Backed or Acquired Cambridge, United Kingdom
You’re viewing 5 of 42 competitors. Get the full list »

X BODY Patents

  • 272

    Total Documents Applications and Grants

  • Total Patents Families

  • 163

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

X BODY Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2800674-T3 Bispecific antigen-binding polypeptides Active 21-Mar-2014
US-10202462-B2 Bi-specific antigen-binding polypeptides Active 21-Mar-2014
US-20150299335-A1 Bi-specific antigen-binding polypeptides Active 21-Mar-2014
US-20190248918-A1 Bi-specific antigen-binding polypeptides Active 21-Mar-2014
AU-2015231155-A1 Bi-specific antigen-binding polypeptides Active 21-Mar-2014 C07K16/32
To view X BODY’s complete patent history, request access »

X BODY Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

X BODY Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
United States Department of the Treasury Government
To view X BODY’s complete investors history, request access »

Ready to get started?

Request a free trial

X BODY FAQs

  • When was X BODY founded?

    X BODY was founded in 2008.

  • Where is X BODY headquartered?

    X BODY is headquartered in Waltham, MA.

  • What is the size of X BODY?

    X BODY has 16 total employees.

  • What industry is X BODY in?

    X BODY’s primary industry is Biotechnology.

  • Is X BODY a private or public company?

    X BODY is a Private company.

  • What is the current valuation of X BODY?

    The current valuation of X BODY is .

  • What is X BODY’s current revenue?

    The current revenue for X BODY is .

  • How much funding has X BODY raised over time?

    X BODY has raised $7.8M.

  • Who are X BODY’s investors?

    United States Department of the Treasury has invested in X BODY.

  • Who are X BODY’s competitors?

    PhoreMost, CytomX Therapeutics, Compass Therapeutics, Mayflower Bioscience, and Abcam are some of the 42 competitors of X BODY.

  • When was X BODY acquired?

    X BODY was acquired on 01-Jun-2015.

  • Who acquired X BODY?

    X BODY was acquired by Juno Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »